Nice close on ORCT yesterday -- a new high close since their earnings blowout and the ensuing consolidation. This breakout likely clears the way for a run to a new high.
Now that ORCT has a second broker covering them, as well as the Oberweiss newsletter this week, all with a buy recommendation, there are lots of buyers interested in getting in on ORCT on any pullbacks. Even at $30, the PE will only be 20, with 35% EPS growth guidance for next year and upside if they add any new customers. As more brokers and institutions discover ORCT, it should continue higher.